Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial

Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial

Background The optimal dosages, timing, and treatment sequencing for standard-of-care neoadjuvant chemoradiotherapy necessitate re-evaluation when used in conjunction with immune checkpoint inhibitors for patients with resectable, locally advanced esophageal squamous cell carcinoma (RLaESCC). The SC...

Full description

Bibliographic Details
Main Authors: Yang Zhao, Yinan Wu, Xue Song, Ning Jiang, Ming Jiang, Si Li, Lijun Zhao, LingLing Gu, Cheng Kong, Xia He, Jingyuan Zhang, Zhen Guo, Binhui Ren, Xiangzhi Zhu
Format: Article
Language:English
Published: BMJ Publishing Group 2024-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/1/e008229.full

Internet

https://jitc.bmj.com/content/12/1/e008229.full

Similar Items